Andrew D. Lipman is Director at NU SKIN ENTERPRISES, INC. (NUS). They have made 10 open-market trades across 1 company since 2011, most recently 2024-05-28.
CIK 0001184208
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NUS | 23,225 | $119K |
Shares reported on the most recent Form 4, priced at the 2024-05-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUS | SELL · 10b5-1 | 2024-05-28 | 2024-05-28 | $13.33 | $27K | +0.3% | -18.2% | -23.8% |
| NUS | SELL · 10b5-1 | 2024-04-25 | 2024-04-25 | $12.34 | $25K | +0.3% | +9.3% | -15.8% |
| NUS | SELL · 10b5-1 | 2024-03-25 | 2024-03-25 | $12.32 | $25K | -0.6% | -1.0% | -8.7% |
| NUS | SELL · 10b5-1 | 2024-02-26 | 2024-02-27 | $12.46 | $25K | +4.5% | +13.5% | +9.5% |
| NUS | SELL · 10b5-1 | 2024-01-25 | 2024-01-25 | $18.55 | $37K | -7.0% | -35.4% | -34.7% |
| NUS | SELL · 10b5-1 | 2023-12-26 | 2023-12-27 | $19.39 | $39K | -3.6% | -2.2% | -33.1% |
| NUS | SELL · 10b5-1 | 2023-11-27 | 2023-11-28 | $17.11 | $34K | +5.9% | +15.7% | -26.3% |
| NUS | SELL | 2023-11-03 | 2023-11-06 | $17.68 | $272K | +4.7% | +3.4% | +4.5% |
| NUS | SELL · 10b5-1 | 2023-10-25 | 2023-10-26 | $19.23 | $38K | -10.8% | -13.7% | -5.3% |
| NUS | SELL · 10b5-1 | 2023-09-25 | 2023-09-25 | $23.02 | $46K | -13.6% | -14.2% | -14.7% |
| NUS | SELL · 10b5-1 | 2023-08-25 | 2023-08-28 | $23.33 | $47K | -2.5% | -11.7% | -30.0% |
| NUS | SELL | 2023-07-25 | 2023-07-25 | $28.99 | $58K | -12.2% | -22.0% | -35.9% |
| NUS | SELL | 2023-06-26 | 2023-06-26 | $32.12 | $128K | -5.8% | -7.9% | -30.1% |
| NUS | SELL | 2023-05-25 | 2023-05-26 | $34.28 | $69K | +1.9% | -5.4% | -32.5% |
| NUS | SELL | 2023-04-25 | 2023-04-25 | $40.75 | $82K | -1.9% | -12.7% | -27.1% |
| NUS | SELL | 2023-03-27 | 2023-03-27 | $39.29 | $79K | +1.6% | -0.5% | -17.8% |
| NUS | SELL · 10b5-1 | 2023-02-22 | 2023-02-23 | $41.42 | $41K | -1.8% | -1.8% | -13.8% |
| NUS | SELL · 10b5-1 | 2023-01-23 | 2023-01-23 | $42.27 | $42K | +4.8% | -1.1% | -2.1% |
| NUS | SELL · 10b5-1 | 2022-12-22 | 2022-12-22 | $40.75 | $41K | +4.3% | +2.4% | -7.2% |
| NUS | SELL · 10b5-1 | 2022-11-22 | 2022-11-22 | $38.16 | $38K | +8.7% | +8.3% | +8.4% |
| NUS | SELL · 10b5-1 | 2022-10-21 | 2022-10-24 | $35.92 | $36K | -12.7% | +5.8% | +15.7% |
| NUS | SELL · 10b5-1 | 2022-09-22 | 2022-09-22 | $36.67 | $37K | -1.6% | +0.4% | +13.2% |
| NUS | SELL · 10b5-1 | 2022-08-22 | 2022-08-22 | $45.01 | $45K | -5.7% | -14.3% | -12.4% |
| NUS | SELL · 10b5-1 | 2022-07-22 | 2022-07-22 | $43.00 | $43K | +5.9% | +3.5% | -15.6% |
| NUS | SELL · 10b5-1 | 2022-06-22 | 2022-06-22 | $44.06 | $44K | +1.6% | -4.2% | -16.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.